Skip to content
OpenCapital
Get started

Chemed CHE Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

HCA Healthcare logo
HCA HealthcareHCA
——

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's payments for repurchase of common stock?
Chemed (CHE) reported payments for repurchase of common stock of $190.04M in Q1 2026.
How has Chemed's payments for repurchase of common stock changed year-over-year?
Chemed's payments for repurchase of common stock increased by 472.0% year-over-year, from $33.22M to $190.04M.
What is the long-term trend for Chemed's payments for repurchase of common stock?
Over 3 years (2021 to 2025), Chemed's payments for repurchase of common stock has grown at a -9.2% compound annual growth rate (CAGR), from $576.04M to $431.5M.
What does payments for repurchase of common stock mean?
The total cash outflow used by the company to buy back its own shares from the open market or through private transactions. This is a primary method for returning capital to shareholders and reducing the total share count to improve earnings per share. High levels of repurchases often signal management's confidence in the company's valuation and future prospects.